Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In 2014, the European Medicines Agency (EMA) approved afamelanotide (Scenesse) for the treatment of EPP, making it the first melanocortin receptor agonist to receive regulatory approval for a medical condition
This helps reduce post-meal blood sugar spikes and can promote a feeling of fullness, potentially supporting weight management
In February 2026, Lilly also introduced multi-dose KwikPen devices through LillyDirect at $299 to $449 per month
Doxycycline and acyclovir are two important medications under investigation for repurposing in AD
US$ 23.88
US$ 23.83
US$ 22.28
US$ 21.59
